At Sanofi, AI has shifted from experimentation to becoming a vital part of our infrastructure.
AI promised to speed up drug discovery, but the real bottleneck is in clinical trials. This startup is using AI to accelerate ...
Large drugmakers once had more room to absorb failure, both financially and reputationally | Large drugmakers are facing tighter constraints than in the past, as financial, scientific and reputational ...
MM+M Agency 100 honoree Calcium+Company supported Sun’s campaign, which also featured partners Skin Cancer Champions, AIM at ...
Prices for GLP-1s are falling fast, forcing companies to adapt.
AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.
The shares of Aurobindo Pharma will be in focus in today's session as the USFDA issued a Form 483 with a total of nine ...
This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...
Novartis CEO Vas Narasimhan received $32.4 million in total realized compensation in 2025, a marked increase compared to his ...
Royalty Pharma Plc (NASDAQ:RPRX) is one of the best healthcare stocks under $50 to invest in. On January 30, Royalty Pharma ...
Trump’s son is on the board of a prescription drug platform that may benefit from the direct-to-patient medicine sales.
Two weeks after launch, 91% of people had confirmed that they had completed the training. That level of visibility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results